Clinical Trial Update: Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Diabetic Vitreous Hemorrhage [Phase 2]

View source ↗

Summary

A Phase 2 trial from the University of Sao Paulo is evaluating intravitreal bevacizumab as an adjuvant to pars plana vitrectomy for diabetic vitreous hemorrhage…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Avastin (bevacizumab) (bevacizumab)

Snippet

Sponsor: University of Sao Paulo | Conditions: Recurrent, Hemorrhage | Phase 2 | Status: UNKNOWN